← Back to search
BIOPHARMA SERVICES USA
COLUMBIA, MO, 65201
UnclaimedClaim this profile (free)
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Food and Drug Administration | NEW TASK ORDER UNDER IDIQ CONTRACT HHSF223201610004I ENTITLED, "A RANDOMIZED, OPEN LABEL, TWO TREATMENT, FOUR PERIOD, SINGLE DOSE, FULLY REPLICATE, CROSSOVER BIOEQUIVALENCE (BE) STUDY OF TACROLIMUS CAPSULES 5 MG" | HHSF223201610004IUSAspending | $1,845,195 | Jun 21, 2024 | Mar 10, 2020 – May 31, 2022 |
| Prime | Department of Health and Human Services Food and Drug Administration | IGF::CL::IGF - NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS | HHSF223201610004IUSAspending | $2,877,830 | Feb 29, 2024 | Sep 13, 2018 – Jul 24, 2024 |
| Prime | Department of Health and Human Services Food and Drug Administration | NEW TASK ORDER UNDER IDIQ CONTRACT HHSF223201610004I, ENTITLED "PHARMACOKINETIC (PK) STUDY OF OPIOID DRUG PRODUCTS FOLLOWING ORAL INGESTION OF CHEWED PRODUCTS | HHSF223201610004IUSAspending | $2,470,791 | Mar 24, 2023 | Sep 16, 2019 – May 31, 2023 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.